Suzette Delaloge
0000-0003-2106-9165
7 papers found
Refreshing results…
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations
Therapeutic vaccines for breast cancer: Has the time finally come?
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Chk1 as a new therapeutic target in triple-negative breast cancer
Missing publications? Search for publications with a matching author name.